Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy W Vandiver

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 26, 2025
Selecting oral antithrombotic therapies in peripheral arterial disease: A guide for practitionersJeremy W Vandiver
Idcases|June 11, 2020
Clostridium perfringens as an unusual cause of a prosthetic joint infection following total knee arthroplastyGina Stroud, Jeremy W Vandiver
Pharmacotherapy|April 26, 2012
Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparinJeremy W Vandiver, Thomas G Vondracek
Journal of Thrombosis and Thrombolysis|February 26, 2018
Combining oral anticoagulation and antiplatelet therapies: appropriate patient selectionJeremy W Vandiver, K Diane Beavers
Hospital Practice (1995)|April 3, 2013
A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoringJeremy W Vandiver, Thomas G Vondracek
Family Medicine|April 9, 2016
Transitions of Care in Medical Education: A Compilation of Effective Teaching MethodsMeagan McBryde, Jeremy W Vandiver, Mary Onysko
Targeted Oncology|March 5, 2016
Severe Hyponatremia and Immune Nephritis Following an Initial Infusion of NivolumabJeremy W Vandiver, Zachary Singer, Cara Harshberger
Journal of Thrombosis and Thrombolysis|May 19, 2015
Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendationsJeremy W Vandiver, Leticia I Ritz, Jeffrey T Lalama
Journal of Investigative Medicine High Impact Case Reports|October 5, 2021
Fanconi Syndrome Induced by Concomitant HIV PrEP and TacrolimusBecky S Linn, Jeremy W Vandiver, Dylan Ren, et al.
The Journal of Family Practice|October 30, 2014
Statin adverse effects: sorting out the evidenceSteven G Mlodinow, Mary K Onysko, Jeremy W Vandiver, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 26, 2025
Selecting oral antithrombotic therapies in peripheral arterial disease: A guide for practitionersJeremy W Vandiver
Idcases|June 11, 2020
Clostridium perfringens as an unusual cause of a prosthetic joint infection following total knee arthroplastyGina Stroud, Jeremy W Vandiver
Pharmacotherapy|April 26, 2012
Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparinJeremy W Vandiver, Thomas G Vondracek
Journal of Thrombosis and Thrombolysis|February 26, 2018
Combining oral anticoagulation and antiplatelet therapies: appropriate patient selectionJeremy W Vandiver, K Diane Beavers
Hospital Practice (1995)|April 3, 2013
A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoringJeremy W Vandiver, Thomas G Vondracek
Family Medicine|April 9, 2016
Transitions of Care in Medical Education: A Compilation of Effective Teaching MethodsMeagan McBryde, Jeremy W Vandiver, Mary Onysko
Targeted Oncology|March 5, 2016
Severe Hyponatremia and Immune Nephritis Following an Initial Infusion of NivolumabJeremy W Vandiver, Zachary Singer, Cara Harshberger
Journal of Thrombosis and Thrombolysis|May 19, 2015
Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendationsJeremy W Vandiver, Leticia I Ritz, Jeffrey T Lalama
Journal of Investigative Medicine High Impact Case Reports|October 5, 2021
Fanconi Syndrome Induced by Concomitant HIV PrEP and TacrolimusBecky S Linn, Jeremy W Vandiver, Dylan Ren, et al.
The Journal of Family Practice|October 30, 2014
Statin adverse effects: sorting out the evidenceSteven G Mlodinow, Mary K Onysko, Jeremy W Vandiver, et al.
Pageof 2